Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Commissioner, Chief Counsel See Wiggle Room In FDA's Legal Powers

This article was originally published in The Gray Sheet

Executive Summary

Putting FDA's aggressive enforcement plan into action will require more creativity on the part of agency lawyers, according to FDA's commissioner and new chief counsel

You may also be interested in...



FDA Chief Counsel Ralph Tyler To Depart In August

Ralph Tyler is leaving FDA 18 months after becoming the agency's chief counsel.

FDA Chief Counsel Ralph Tyler To Depart In August

Ralph Tyler is leaving FDA 18 months after becoming the agency's chief counsel.

Steris Agrees To Consent Order With FDA To Resolve Sterilizer Problems

Steris is offering credits and rebates to users of its troubled System 1 liquid chemical sterilization system under a transition plan called for in an April 19 consent decree with FDA

Related Content

Topics

UsernamePublicRestriction

Register

MT028818

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel